4
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Decision Analysis of Estrogen and Progesterone Receptor Testing in the Management of Breast Cancer

&
Pages 83-88 | Published online: 11 Jun 2009
 

Abstract

Estrogen receptor (ER) and progesterone receptor (PR) assays are used to guide the hormonal treatment of metastatic/recurrent carcinoma of the breast. Sensitivity, specificity, and predictive value were calculated in comparing no receptor testing, ER testing alone, PR testing alone, and ER and PR in parallel. Analyses demonstrate that the indications for utilizing receptor assays are influenced by the valuation of uncertain outcomes and whether hormonal therapy is routinely planned in the absence of receptor test information. The PR assay appears best suited when patient outcome values mandate minimizing the likelihood of a false-positive outcome, with a corresponding increase in the likelihood of a true-negative outcome, even if this results in a reduced chance of a true-positive outcome and an increased chance of a false-negative outcome. Test specificity gives PR an advantage in this case. The ER assay has a comparative advantage when there is little difference in value between true-negative and false-positive outcomes and the primary contribution of testing is to maximize true-positive outcomes, while correspondingly minimizing the false-negative outcomes. This requires high test sensitivity. In either case, parallel testing does not appear to add appreciably to single test performance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.